Research scientist John Okonya works in the chemistry lab at Sanofi in Oro Valley.
Arizona's biosciences sector added jobs at nearly four times the national rate over the decade ending in 2011, a new report shows.
Dr. Evan Unger and his four-year-old Tucson company, NuvOx Pharma, are planning clinical trials of an injectable drug to make tumors more susceptible to radiation treatment.
Nearly two decades ago, University of Arizona radiologist Dr. Evan Unger recognized that an ultrasound imaging contrast agent he pioneered held promise as a way to deliver drugs or therapies to specific areas.
Caleb Sutherland, a student in cancer biology doctoral program, works in a lab at Bio5's Thomas W. Keating Bioresearch Building on the University of Arizona campus. Bio5 is a collaborative research center that integrates five disciplines.
The region's private biosciences employment, such as Sanofi in Oro Valley, has grown 41 percent over eight years.
Ten years after Arizona launched a major initiative to become a leader in the biosciences, the state is still a small player compared with bio bastions like California and Massachusetts.
Thursday's event included dedication of this tile-wall artwork created by students at Las Artes as part of a new "Pathway to Discovery" interpretive trail. The UA hopes the first biotech building will rise soon.
Those attending the dedication heard UA officials and local dignitaries praise the UA BioPark as emblematic of a bright future for Tucson.
After more than a decade of planning and nearly three years after its groundbreaking, the University of Arizona Bioscience Park is celebrating the end of the beginning.
Oro Valley-based Ventana Medical Systems said it is introducing a first-of-its-kind, fully-automated sample staining technique that will allow researchers to examine two key indicators related to cancer in the same section of tumor tissue.
Bruce Seligmann, who founded HTG Molecular Diagnostics 15 years ago, was back in the lab on Thursday, where he's working on the company's next generation diagnostic platform and other new projects, including a new research arrangement with the UA College of Pharmacy.
You'll no longer find Bruce Seligmann's mustachioed mug among the directors listed on the website of the company he founded some 15 years ago.
A prototype solar energy system designed by University of Arizona astronomy professor Roger Angel is tested in a courtyard between buildings on the UA campus. A fully functional system is under construction at the UA Science and Technology Park.
Mark Schwartz, a scientist, works at HTG Molecular Diagnostics Inc. at 3430 E. Global Loop, near South Palo Verde and East Valencia roads. The biotech company is expanding into new products.
Lab technician Becky Eichorst makes polymers at Medipacs, which operates at the Arizona Center for Innovation's "wet lab."
David Galbraith, center, a plant geneticist and professor, tests out a plate transfer robot at the Bio5 Institute at the University of Arizona.
Five years after its inception and nearly three years after losing most of its state funding, Arizona's public-private science partnership is still bearing fruit - particularly in Southern Arizona.
NEW YORK — Large acquisitions from Abbott Laboratories, Xerox
Corp. and Johnson & Johnson vaulted shares of drugmakers and
technology companies higher Monday.